Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Talanta ; 241: 123268, 2022 May 01.
Article in English | MEDLINE | ID: mdl-35121537

ABSTRACT

European and national waste directives prioritize recycling of wastes, as well as material and energy recovery from wastes themselves. Bio-waste fraction can be converted into new resources whose quality is strictly dependent upon that of waste feedstock. Methods to evaluate the contamination from organic micropollutants in bio-waste are rarely investigated. The aim of this work was to develop an innovative analytical method for the extraction and quantification of 16 polycyclic aromatic hydrocarbons (PAHs) and 14 polychlorinated biphenyls (PCBs, including dioxin-like compounds) in bio-waste. Through a full-factorial experimental design, a microwave-assisted extraction technique was optimized to extract the thirty targeted micropollutants, studying the effect of cyclohexane and dichloromethane as extraction solvents with or without acetone, and of extraction temperature. Purification of the extract was obtained by a silica-based solid-phase extraction cartridge, followed by a sulfuric acid treatment. The analysis was carried out by gas chromatography coupled with mass spectrometry. The optimized method, validated directly in the bio-waste matrix fortified with isotopically marked surrogates, is characterized by good extraction recoveries, included within 47 and 106% (relative standard deviations <10%), by satisfactory intra-day (<1.1%) and inter-day (<9.3%) precision, and by low matrix effect (<17%), despite the complexity of the matrix. The optimized procedure, applied to the analysis of PAHs and PCBs in a bio-waste sample collected from a local anaerobic digestion and composting plant, showed a total PAHs content of 562 µg/kg. As regards PCBs, the dioxin-like congener PCB 118 was the only compound quantified (25 ± 6 µg kg-1).


Subject(s)
Polychlorinated Biphenyls , Polycyclic Aromatic Hydrocarbons , Gas Chromatography-Mass Spectrometry/methods , Microwaves , Polychlorinated Biphenyls/analysis , Polycyclic Aromatic Hydrocarbons/analysis , Solid Phase Extraction , Solid Waste/analysis
2.
Neuropsychobiology ; 57(1-2): 38-43, 2008.
Article in English | MEDLINE | ID: mdl-18451636

ABSTRACT

BACKGROUND/AIMS: The aim of this study was to investigate the serotonin transporter (SERT), by means of the 3H-paroxetine ([3H]-Par) binding to platelet membranes, in patients affected by pathological gambling (PG), as compared with a similar group of healthy control subjects. METHODS: Seventeen PG patients were selected amongst those who were drug-free and at the first psychiatric interview in a Department of Addiction. The diagnosis was assessed according to DSM-IV criteria and PG severity was measured by means of the South Oaks Gambling Screen. The platelet [3H]-Par binding was carried out according to a standardized method. The binding parameters, the maximum binding capacity (B(max)) and the dissociation constant (K(d)), were obtained by means of the Scatchard analysis. RESULTS: The B(max) values of PG patients were significantly lower than that of healthy subjects, while the K(d) values were not different in the two groups. No significant effect of age, sex or psychiatric comorbidity on B(max) or K(d) was observed; there were also no correlations between clinical and biological variables. CONCLUSIONS: PG patients showed a dysfunction at the level of the platelet SERT that would suggest the involvement of the 5-HT system in this condition.


Subject(s)
Blood Platelets/pathology , Disruptive, Impulse Control, and Conduct Disorders/blood , Gambling/psychology , Serotonin Plasma Membrane Transport Proteins/blood , Adult , Binding Sites , Cell Count , Demography , Diagnostic and Statistical Manual of Mental Disorders , Disruptive, Impulse Control, and Conduct Disorders/diagnosis , Disruptive, Impulse Control, and Conduct Disorders/drug therapy , Female , Humans , Male , Paroxetine/pharmacokinetics , Paroxetine/therapeutic use , Platelet Membrane Glycoproteins/metabolism , Selective Serotonin Reuptake Inhibitors/pharmacokinetics , Selective Serotonin Reuptake Inhibitors/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...